16 articles for NP Walker
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11 beta-HSD1 inhibitors.

Amgen
Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors.

Amgen
Distinctive molecular inhibition mechanisms for selective inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.

Amgen
Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4.

Amgen
Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ).

Arcus Biosciences
SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase.

Amgen
Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors.

Arcus Biosciences
Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors.

Arcus Biosciences
Discovery of Potent and Selective PI3Kγ Inhibitors.

Arcus Biosciences
Discovery of AB680: A Potent and Selective Inhibitor of CD73.

Arcus Biosciences
Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73.

Arcus Biosciences
Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4.

Amgen
Therapeutic compounds, compositions and methods of use thereof

Genentech
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

H. Lundbeck
3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection

Hoffmann-La Roche
Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease.

National Taiwan University